Tel Aviv NeuroAI company Hemispheric emerges with $52M

Hemispheric, a Tel Aviv-based NeuroAI company building a platform to measure and understand the human brain, has emerged from stealth with 52 million dollars in funding, FinSMEs reports. The company said it intends to use the capital to expand deployment of its Descartes platform, grow what it describes as a global brain-data network, and scale its team in the United States.

According to the report, Descartes is designed to work with government, healthcare and pharmaceutical partners, and the company plans to advance regulatory pathways for what it calls precision diagnostics. The funding is aimed at broadening the platform's use among those partners while the company continues to develop its underlying technology.

The round drew a broad group of backers. FinSMEs lists investors including Hanaco Ventures, OneMind and Awareness Capital, Protocol Labs, L Catterton, Arkin Capital, and individual investors such as Howard Morgan, Naomi Azrieli, Yasmin Lukatz and Scott Belsky, among others. The mix of venture funds and strategic angels reflects the range of interest in companies working at the intersection of neuroscience and artificial intelligence.

Hemispheric's launch adds another deep-technology company to Tel Aviv's dense start-up ecosystem, which already spans cybersecurity, fintech and enterprise software. The city and its surrounding metropolitan area host a large share of Israel's research-and-development activity, and companies frequently keep their core engineering teams in the Tel Aviv area while building sales and partnership operations abroad.

Brain-measurement and NeuroAI remain emerging fields, and the practical impact of any single platform will depend on validation, regulatory approval and adoption by the healthcare and research institutions it aims to serve. The company framed its emergence from stealth as the start of wider deployment rather than a finished product.

For the Tel Aviv technology scene, the funding is a signal that investor appetite extends beyond the security and software sectors that have dominated recent activity, reaching into health and neuroscience. It also continues a pattern of Israeli founders raising substantial early rounds while anchoring their scientific and engineering work in the metropolitan area.

Sources: finsmes.com.

This article is general information only and is not personal financial or investment advice. Consider your own circumstances and seek licensed professional advice before making financial decisions.